sales were down 29% primarily due to the impact of competition on unit demand and net selling price.
The principal finding was that the biosimilar filgrastim, Leucostim, was as effective as the original drug, Neupogen
, for prophylaxis of chemotherapy-induced neutropenia and its complications.
He added that some of the medicines, which ran out of stocks, were the Chemotherapy drugs and the Neupogen
injections used to boost cancer patients' Immune system.
This donation will provide cancer patients in 18 developing countries with access to Neulasta (pegfilgrastim), NEUPOGEN
(filgrastim) and Vectibix (panitumumab).
Kudra also reported that the drug called Neupogen
, which strengthens the immune system, as well as chemotherapy drugs, have completely run out.
She was given three doses of Neupogen
for severe leucopenia.
De los datos reportados en de la tabla 4, en la que se compararon medicamentos biologicos pioneros con algunos de sus biosmilares, a partir de presentaciones del medicamento cuyas dosis son equivalentes, se evidencia que las diferencias de precios entre los biologicos pioneros y los biosimilares pueden ser significativas en terminos porcentuales, llegando a una diferencia superior al 50 %, como en el caso Clexane [R] y Neupogen
[R] con sus biosimilares Enoxaparina sodica y Enoxpar, lo cual puede impactar la toma de decisiones dentro del sistema, en especial en el profesional de la salud y el paciente (consumidor), quien no recibe una informacion clara al respecto.
'These brands include Zantac tablets and injection, Risperdal tablets, Concord tablets, Cefspan capsules and suspension, Fortum injections, Ciproxin tablets and infusion, Canesten-V tablets and cream, Caflam tablets, Zovirax injection, tablets and cream, Amikin injection, Imuran tablets, Neupogen
injections, Prozac syrup, Engirex B injection, Cravit tablets, Singulair tablets and sachets, Cell Cept tablets, Losec infusion, Tamiflu capsules, Taxol injection, Eprex injection.
marketplace include Amgen's Mvasi (bevacizumab-awwb), a biosimilar to Avastin from Genentech; Boehringer Ingelheim's Cyltezo (adalimumabadbm) and Amgen's Amjevita (adalimumab-atto), both biosimilars to Humira from Abb Vie; Samsung Bioepis' Renflexis (infliximab-abda) and Pfizer/ Celltrion's Inflectra (infliximab-dyyb), biosimilars of Janssen/Johnson & Johnson's Remicade; Sandoz's Erelzi (etanercept-szzs), a biosimilar of Amgen's Enbrel; and Zarxio (filgrastimsndz), a Sandoz biosimilar of Amgen's Neupogen
. Zarxio, an oncology medication, was the first FDA-approved biosimilar product.
Soft but Reliable Growth: Growth of a number of established products, XGEVA (bone metastases), Prolia (osteoporosis), Nplate (thrombocytopenia), Vectibix (metastatic colorectal cancer), and Sensipar (secondary hyperparathyroidism), should help to offset some of the risk of anticipated branded and biosimilar competition against Neulasta and Epogen and existing competition against Neupogen
Over time, the scope of the collaboration was expanded to include NEUPOGEN
(filgrastim), Neulasta (pegfilgrastim), Aranesp (darbepoetin alfa), Nplate (romiplostim) and brodalumab.